Lopes, E.; Machado-Oliveira, G.; Simões, C.G.; Ferreira, I.S.; Ramos, C.; Ramalho, J.; Soares, M.I.L.; Melo, T.M.V.D.P.e.; Puertollano, R.; Marques, A.R.A.;
et al. Cholesteryl Hemiazelate Present in Cardiovascular Disease Patients Causes Lysosome Dysfunction in Murine Fibroblasts. Cells 2023, 12, 2826.
https://doi.org/10.3390/cells12242826
AMA Style
Lopes E, Machado-Oliveira G, Simões CG, Ferreira IS, Ramos C, Ramalho J, Soares MIL, Melo TMVDPe, Puertollano R, Marques ARA,
et al. Cholesteryl Hemiazelate Present in Cardiovascular Disease Patients Causes Lysosome Dysfunction in Murine Fibroblasts. Cells. 2023; 12(24):2826.
https://doi.org/10.3390/cells12242826
Chicago/Turabian Style
Lopes, Elizeth, Gisela Machado-Oliveira, Catarina Guerreiro Simões, Inês S. Ferreira, Cristiano Ramos, José Ramalho, Maria I. L. Soares, Teresa M. V. D. Pinho e Melo, Rosa Puertollano, André R. A. Marques,
and et al. 2023. "Cholesteryl Hemiazelate Present in Cardiovascular Disease Patients Causes Lysosome Dysfunction in Murine Fibroblasts" Cells 12, no. 24: 2826.
https://doi.org/10.3390/cells12242826
APA Style
Lopes, E., Machado-Oliveira, G., Simões, C. G., Ferreira, I. S., Ramos, C., Ramalho, J., Soares, M. I. L., Melo, T. M. V. D. P. e., Puertollano, R., Marques, A. R. A., & Vieira, O. V.
(2023). Cholesteryl Hemiazelate Present in Cardiovascular Disease Patients Causes Lysosome Dysfunction in Murine Fibroblasts. Cells, 12(24), 2826.
https://doi.org/10.3390/cells12242826